Interstitial Lung Disease 2 (ILD2)

Interstitial Lung Disease 2(来自ICD-11)

别称:

Idiopathic Pulmonary Fibrosis

Ipf

Pulmonary Fibrosis, Idiopathic, Susceptibility to

Fibrocystic Pulmonary Dysplasia

Pulmonary Fibrosis, Idiopathic

Idiopathic Pulmonary Fibrosis, Familial

Cryptogenic Fibrosing Alveolitis

Usual Interstitial Pneumonia

Ild2

Uip

Idiopathic Fibrosing Alveolitis, Chronic Form

Idiopathic Pulmonary Fibrosis Familial

Chronic Idiopathic Pulmonary Fibrosis

Ipf - [idiopathic Pulmonary Fibrosis]

Fibrosing Alveolitis, Cryptogenic

Fibrosing Alveolitis Cryptogenic

Interstitial Pneumonitis, Usual

Fibrosis, Pulmonary, Idiopathic

Interstitial Pulmonary Fibrosis

Interstitial Pneumonitis Usual

Fibrosis Idiopathic Pulmonary

Acute Interstitial Pneumonia

Idiopathic Lung Fibrosis

Fibrosing Lung Disease

Pulmonary Fibrosis Nos

Fibrosing Pneumonitis

Hamman-Rich Syndrome

Fibrosing Alveolitis

Hamman-Rich Disease

加入收藏

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Interstitial Lung Disease 2, also known as idiopathic pulmonary fibrosis, is related to localized pulmonary fibrosis and pulmonary fibrosis, and has symptoms including dyspnea on exertion and dry cough. An important gene associated with Interstitial Lung Disease 2 is SFTPA2 (Surfactant Protein A2), and among its related pathways/superpathways are Diseases of glycosylation and Complement cascade. The drugs Nintedanib and Analgesics, Non-Narcotic have been mentioned in the context of this disorder. Affiliated tissues include Placenta, Adipose and lung, and related phenotypes are abnormal pulmonary interstitial morphology and gastroesophageal reflux

查看原文参与反馈